Quadrature Capital’s Amedisys AMED Stock Holding History

Quadrature Capital’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,598	Closed	-$1.47M	–	897
2022 Q4	$1.47M	Buy	+17,598	New	+$1.59M	0.04%	284
2021 Q4	–	Sell	-33,316	Closed	-$4.97M	–	674
2021 Q3	$4.97M	Buy	33,316 +26,308	+375%	+$5.47M	0.18%	90
2021 Q2	$1.72M	Buy	+7,008	New	+$1.84M	0.07%	212
2020 Q4	–	Sell	-8,039	Closed	-$1.9M	–	813
2020 Q3	$1.9M	Buy	+8,039	New	+$1.83M	0.11%	220
2019 Q2	–	Sell	-4,035	Closed	-$498K	–	428
2019 Q1	$498K	Buy	+4,035	New	+$506K	0.04%	326
2017 Q4	–	Sell	-5,226	Closed	-$292K	–	496
2017 Q3	$292K	Buy	+5,226	New	+$276K	0.04%	337

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Quadrature Capital's AMED Position: Q1 2023 in Review

Quadrature Capital sold out of Amedisys (AMED) in Q1 2023, closing a stake of 17,598 shares — an estimated $1.47M sold.

Quadrature Capital first reported a position in AMED in Q3 2017 and held it in 6 quarters. The position peaked at $4.97M in Q3 2021. 281 funds tracked by Wall St. Rank hold AMED as of Q1 2023.

Quadrature Capital reported no remaining Amedisys position as of Q1 2023 after selling out during the quarter.
Quadrature Capital sold 17,598 Amedisys shares in Q1 2023, an estimated $1.47M.
Quadrature Capital first reported a position in Amedisys in Q3 2017 and held it in 6 quarters.
Quadrature Capital's Amedisys position peaked at $4.97M in Q3 2021.
281 funds tracked by Wall St. Rank held Amedisys as of Q1 2023.

Based on Quadrature Capital's 13F filing for Q1 2023, filed 15 May 2023.